(MENAFN- EIN Presswire)
Rising Demand for Early Diagnostics and Advancements in Biomarker Discovery Drive Growth in China's Exosome Research Products Market
CHICAGO, NY, UNITED STATES, November 1, 2024 /EINPresswire / -- The China exosome research products
market is on a trajectory of significant growth, valued at approximately US$ 15.59 million in 2023. According to recent
industry reports, this market is projected to reach an impressive US$ 148.93 million by 2032, reflecting a robust compound annual growth rate (CAGR) of 28.5% over the forecast period from 2024 to 2032.
The Request of this Sample Report Here-
Exosomes, small extracellular vesicles released by cells, are gaining recognition for their potential in various biomedical applications, including diagnostics, drug delivery, and therapeutic interventions. The increasing prevalence of chronic diseases, coupled with rising investments in research and development, is driving the demand for exosome research products in China.
Key factors contributing to this growth include advancements in exosome isolation and characterization technologies, increased funding for exosome-related research, and the growing adoption of personalized medicine. Furthermore, the expansion of biotechnology and pharmaceutical industries in China is expected to create ample opportunities for market players.
TransGen Biotech Co., Ltd.
Creative Biostructure
Lonza
Thermo Fisher Scientific Inc.
Fujifilm Holdings Corporation
QIAGEN
Bio-Techne Corporation
Miltenyi Biotec
Beckman Coulter, Inc. (Danaher Corporation)
Norgen Biotek Corp.
Other Prominent Players
Leading companies in the exosome research products sector are focusing on innovative product development and strategic partnerships to enhance their market presence and cater to the evolving needs of researchers and healthcare professionals.
As the market continues to evolve, stakeholders are encouraged to stay informed about emerging trends and technological advancements that are shaping the future of exosome research.
For more information, please contact:
Top Players in China Exosome Research Products Market
TransGen Biotech Co., Ltd.
Creative Biostructure
Lonza
Thermo Fisher Scientific Inc.
Fujifilm Holdings Corporation
QIAGEN
Bio-Techne Corporation
Miltenyi Biotec
Beckman Coulter, Inc. (Danaher Corporation)
Norgen Biotek Corp.
Other Prominent Players
Market Segmentation Overview:
By Offering
Kits & Reagents
Antibodies
Quantification Kits
Isolation Tools
DNA-RNA Extraction Kits
Biomarker and Discovery
Engineering & Design Products
Others
Instruments
Services
By Indication
Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other Cancers
Non-Cancer
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Others
By Application
Therapeutics
Diagnostic
Regenerative Medicine
Medical Aesthetics
Others
By End User
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
CDMO
Biopharma
Hospital & Clinical Testing Laboratories
Download Sample PDF Report@-
About Astute Analytica:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
Aamir Beg
Astute Analytica
+1 888-429-6757
email us here
Visit us on social media:
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN01112024003118003196ID1108841065
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.